Miura, Y.; Imai, H.; Endo, S.; Hashimoto, K.; Yamaguchi, O.; Mouri, A.; Masubuchi, K.; Masubuchi, T.; Fujita, Y.; Kato, S.;
et al. Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers. Curr. Oncol. 2026, 33, 135.
https://doi.org/10.3390/curroncol33030135
AMA Style
Miura Y, Imai H, Endo S, Hashimoto K, Yamaguchi O, Mouri A, Masubuchi K, Masubuchi T, Fujita Y, Kato S,
et al. Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers. Current Oncology. 2026; 33(3):135.
https://doi.org/10.3390/curroncol33030135
Chicago/Turabian Style
Miura, Yu, Hisao Imai, Satoshi Endo, Kosuke Hashimoto, Ou Yamaguchi, Atsuto Mouri, Ken Masubuchi, Takeshi Masubuchi, Yuka Fujita, Shingo Kato,
and et al. 2026. "Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers" Current Oncology 33, no. 3: 135.
https://doi.org/10.3390/curroncol33030135
APA Style
Miura, Y., Imai, H., Endo, S., Hashimoto, K., Yamaguchi, O., Mouri, A., Masubuchi, K., Masubuchi, T., Fujita, Y., Kato, S., Kagamu, H., & Kaira, K.
(2026). Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers. Current Oncology, 33(3), 135.
https://doi.org/10.3390/curroncol33030135
